<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Immun Inflamm Dis</journal-id><journal-id journal-id-type="iso-abbrev">Immun Inflamm Dis</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2050-4527</journal-id><journal-id journal-id-type="publisher-id">IID3</journal-id><journal-title-group><journal-title>Immunity, Inflammation and Disease</journal-title></journal-title-group><issn pub-type="epub">2050-4527</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29542268</article-id><article-id pub-id-type="pmc">5946145</article-id><article-id pub-id-type="doi">10.1002/iid3.218</article-id><article-id pub-id-type="publisher-id">IID3218</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults</article-title><alt-title alt-title-type="right-running-head">OIT in severe food allergy in adults</alt-title><alt-title alt-title-type="left-running-head">J. M&#x000e4;ntyl&#x000e4; <italic>et al.</italic></alt-title></title-group><contrib-group><contrib id="iid3218-cr-0001" contrib-type="author"><name><surname>M&#x000e4;ntyl&#x000e4;</surname><given-names>Jarkko</given-names></name><xref ref-type="aff" rid="iid3218-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="iid3218-cr-0002" contrib-type="author"><name><surname>Thomander</surname><given-names>Tuuli</given-names></name><xref ref-type="aff" rid="iid3218-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="iid3218-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="iid3218-cr-0003" contrib-type="author"><name><surname>Hakulinen</surname><given-names>Auli</given-names></name><xref ref-type="aff" rid="iid3218-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="iid3218-cr-0004" contrib-type="author"><name><surname>Kukkonen</surname><given-names>Kaarina</given-names></name><xref ref-type="aff" rid="iid3218-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="iid3218-cr-0005" contrib-type="author"><name><surname>Palosuo</surname><given-names>Kati</given-names></name><xref ref-type="aff" rid="iid3218-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="iid3218-cr-0006" contrib-type="author"><name><surname>Voutilainen</surname><given-names>Helena</given-names></name><xref ref-type="aff" rid="iid3218-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="iid3218-cr-0007" contrib-type="author"><name><surname>Pelkonen</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="iid3218-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="iid3218-cr-0008" contrib-type="author" corresp="yes"><name><surname>Kauppi</surname><given-names>Paula</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1065-330X</contrib-id><address><email>paula.kauppi@hus.fi</email></address><xref ref-type="aff" rid="iid3218-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="iid3218-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Respiratory Diseases and Allergology</named-content>
<institution>University of Helsinki and Helsinki University Hospital, Skin and Allergy Hospital</institution>
<named-content content-type="country-part">Helsinki</named-content>
<country country="FI">Finland</country>
</aff><aff id="iid3218-aff-0002">
<label><sup>2</sup></label>
<institution>University of Eastern Finland</institution>
<named-content content-type="city">Kuopio</named-content>
<country country="FI">Finland</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Paula Kauppi, MD, PhD, Skin and Allergy Hospital,<break/>
Meilahdentie 2, P.O. Box 160, FI&#x02010;00029 HUS, Helsinki, Finland.<break/>
Tel:&#x02009;+&#x02009;358 9 471 86523<break/>
Fax: +358 9 471 86503<break/>
E&#x02010;mail: <email>paula.kauppi@hus.fi</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2018</year></pub-date><volume>6</volume><issue>2</issue><issue-id pub-id-type="doi">10.1002/iid3.2018.6.issue-2</issue-id><fpage>307</fpage><lpage>311</lpage><history><date date-type="received"><day>11</day><month>12</month><year>2017</year></date><date date-type="rev-recd"><day>23</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>15</day><month>2</month><year>2018</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 John Wiley & Sons Ltd. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2018 The Authors. <italic>Immunity, Inflammation and Disease</italic> Published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:IID3-6-307.pdf"/><abstract><title>Abstract</title><sec id="iid3218-sec-0001"><title>Introduction</title><p>The standard care of severe food allergy in both adults and children means avoidance of allergens. In recent years promising results of oral immunotherapy (OIT) have been reported in children. In adults, information on OIT in severe food allergy is very limited.</p></sec><sec id="iid3218-sec-0002"><title>Objective</title><p>We aimed to study if OIT is possible in adults.</p></sec><sec id="iid3218-sec-0003"><title>Methods</title><p>We report OIT results in 10 adult patients with milk OIT, nine adult patients with peanut OIT, and four adult patients with egg OIT. The allergy was confirmed with allergen specific IgE tests and oral food challenges (open in milk allergy and double&#x02010;blind in peanut and egg allergy). The OIT was performed as open.</p></sec><sec id="iid3218-sec-0004"><title>Results</title><p>The median dose of protein that led to discontinuation of allergen challenge because of symptoms was 7.5&#x02009;mg in milk allergy, 25&#x02009;mg in peanut allergy, and 15&#x02009;mg in egg allergy. The median period of OIT was 515 days. Currently on OIT are 6/10 milk allergic patients, 4/9 peanut allergic patients and 3/4 egg allergic patients. The median dose of milk protein increased by 60&#x02010;fold during OIT compared to the allergen challenge dose. In peanut OIT the median dose increased by eightfold and in egg allergy the dose increased with OIT by 35&#x02010;fold. Local itching was the most common side effect of OIT (73.9% of the patients), four patients reported having used epinephrine autoinjector and three patients having needed emergency room treatment.</p></sec><sec id="iid3218-sec-0005"><title>Conclusions and Clinical Relevance</title><p>OIT can be given in adult patients with severe milk, peanut, or egg allergy only in selected cases. OIT leads into desensitization but it is not clear whether persistent tolerance can be achieved. Mild adverse events during OIT are common.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="iid3218-kwd-0001">Desensitization</kwd><kwd id="iid3218-kwd-0002">food allergy</kwd><kwd id="iid3218-kwd-0003">tolerance</kwd></kwd-group><funding-group><award-group><funding-source>Helsinki University Hospital</funding-source><award-id>HUS evo</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="2"/><page-count count="5"/><word-count count="2580"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>iid3218</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2018</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.8.2 mode:remove_FC converted:11.05.2018</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="iid3218-note-0002"><p>
<bold>Funding information</bold>
</p></fn><fn id="iid3218-note-0003"><p>The study was funded by the Helsinki University Hospital research grant (HUS evo).</p></fn></fn-group></notes></front><body><sec id="iid3218-sec-0006"><title>Introduction</title><p>The standard care of severe food allergy consists of strict food allergen avoidance and emergency self&#x02010;administered drugs (epinephrine injection, oral antihistamines, and glucocorticoid tablets) in case of accidental exposure <xref rid="iid3218-bib-0001" ref-type="ref">1</xref>. OIT has been studied as a treatment option with promising results both in milk, peanut and egg allergy in children and adolescents <xref rid="iid3218-bib-0002" ref-type="ref">2</xref>, <xref rid="iid3218-bib-0003" ref-type="ref">3</xref>, <xref rid="iid3218-bib-0004" ref-type="ref">4</xref>, <xref rid="iid3218-bib-0005" ref-type="ref">5</xref>, <xref rid="iid3218-bib-0006" ref-type="ref">6</xref>. In adults, the information on OIT is mostly lacking.</p><sec id="iid3218-sec-0007"><title>Study population</title><p>Alltogether 41 adult patients aged 18&#x02013;64 years have been screened for possible OIT because of severe food allergy (Fig. <xref rid="iid3218-fig-0001" ref-type="fig">1</xref>). The diagnosis of food allergy was based on positive history, milk, peanut or egg allergen specific IgE antibodies and oral food challenge test which was open label in milk allergy. All the patients had a clinical history of systemic allergic reaction, emergency medication use and emergency visits because of this food allergy. Of these, 10 patients have started milk OIT, nine patients peanut OIT, and four egg OIT. The study was accepted by the Ethical Committee of Helsinki University Hospital (218/13/03/01/2012) and registered as a clinical trial number HUS21813030112. The patients gave a written informed consent for the study.</p><fig fig-type="Figure" xml:lang="en" id="iid3218-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>All the patients that were recruited for OIT.</p></caption><graphic id="nlm-graphic-3" xlink:href="IID3-6-307-g002"><permissions><copyright-holder>Copyright &#x000a9; 2017 Wiley Periodicals, Inc.</copyright-holder></permissions></graphic></fig><p>Patient history data were collected by questionnaires. All patients underwent a spirometry with a bronchodilatator test, exhaled nitric oxide and a methacholine challenge before <xref rid="iid3218-bib-0007" ref-type="ref">7</xref>. Serum samples were taken for specific IgE and allergen component evaluation (Thermo Fisher Scientific, Uppsala, Sweden) before and after OIT.</p></sec><sec id="iid3218-sec-0008"><title>Allergen specific challenge tests</title><p>For milk allergy, increasing doses were given every 60&#x02009;min in an open food challenge. The patients were followed for allergic symptoms and treated when necessary with antihistamines (cetirizine 10&#x02009;mg), prednisolone (40&#x02009;mg) and epinephrine (0.5&#x02009;mg im). In peanut and egg allergy, the allergen challenge was performed in a double&#x02010;blind manner with increasing doses <xref rid="iid3218-bib-0006" ref-type="ref">6</xref>, <xref rid="iid3218-bib-0008" ref-type="ref">8</xref>. Stopping of the challenge tests was done early according to the symptoms. All the patients had a clinical history of anaphylaxis, were sensitized (IgE positive) against storage proteins of the food and had a high risk of anaphylaxis in the challenge test. Lack of intensive care unit at our hospital building guided our challenge test performance <xref rid="iid3218-bib-0009" ref-type="ref">9</xref>.</p></sec><sec id="iid3218-sec-0009"><title>Oral immunotherapy</title><p>The OIT was started at the hospital and was continued daily at home. The milk immunotherapy was started with diluted milk (1:10). After the starting dose the dose was increased according to the protocol <xref rid="iid3218-bib-0010" ref-type="ref">10</xref>, <xref rid="iid3218-bib-0011" ref-type="ref">11</xref>, <xref rid="iid3218-bib-0012" ref-type="ref">12</xref>. For peanut OIT, the peanut protein containing margarine was used in the beginning (roasted defatted peanut flour [Byrd Mill, Ashland, VA] was mixed with Keiju margarine [Raisio, Raisio, Finland]) <xref rid="iid3218-bib-0009" ref-type="ref">9</xref>. In egg allergy, OIT was started with liquid egg white protein with concentrations of 1&#x02009;mg/ml and 10&#x02009;mg/ml and then continued with egg white protein powder (Dava Food Finland, Piispanristi, Finland) <xref rid="iid3218-bib-0012" ref-type="ref">12</xref>. During the escalation phase, six of the increased doses in milk OIT, eight of the peanut OIT, and eight of the egg OIT were given at the hospital.</p></sec><sec id="iid3218-sec-0010"><title>Statistical analyses</title><p>Comparison of IgE tests and age was performed with Mann&#x02010;Whitney <italic>U</italic>&#x02010;test. Comparison of categoric variables was performed by &#x003c7;<sup>2</sup>&#x02010;test. Comparison of IgE and lung function parameter results during OIT were performed with Wilcoxon signed rank test. The tests were performed with software IBM SPSS Statistics 24 (IBM, Armonk, NY).</p></sec></sec><sec id="iid3218-sec-0011"><title>The Results</title><p>All the patients with intention to treat with OIT were on average 31 years old and 81% of them were women (Table <xref rid="iid3218-tbl-0001" ref-type="table-wrap">1</xref>). All the peanut allergic patients reported local itching and irritation in throat and mouth. Egg allergic patients complained stomach pain and nausea more often (28.6% of the patients) than milk allergic (18.2%) or peanut allergic patients (22.2%). The median dose of milk protein in OIT is 450&#x02009;mg and increased by 60&#x02010;fold during OIT. In peanut OIT the median dose is 200&#x02009;mg of peanut protein and increased by eightfold during OIT. In egg allergy, the median dose in OIT was 525&#x02009;mg and increased with OIT by 35&#x02010;fold. Altogether, the median period on OIT was 515 days.</p><table-wrap id="iid3218-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographics of those who were screened or started OIT and allergen specific IgE values before OIT</p></caption><table frame="hsides" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Challenge negative patients</th><th align="center" valign="bottom" rowspan="1" colspan="1">All the screened patients</th><th align="center" valign="bottom" rowspan="1" colspan="1">All who started OIT</th><th align="center" valign="bottom" rowspan="1" colspan="1">Those who quitted OIT</th><th align="center" valign="bottom" rowspan="1" colspan="1">OIT</th><th align="center" valign="bottom" rowspan="1" colspan="1">Challenge negative vs. OIT (p)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Quitted vs. OIT (p)</th></tr></thead><tbody><tr><td colspan="8" align="left" rowspan="1">Age</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean (years)</td><td align="char" char="." rowspan="1" colspan="1">43.0</td><td align="char" char="." rowspan="1" colspan="1">30.7</td><td align="char" char="." rowspan="1" colspan="1">31.6</td><td align="char" char="." rowspan="1" colspan="1">29.3</td><td align="char" char="." rowspan="1" colspan="1">33.4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">38.0</td><td align="char" char="." rowspan="1" colspan="1">26.0</td><td align="char" char="." rowspan="1" colspan="1">33.0</td><td align="char" char="." rowspan="1" colspan="1">29.5</td><td align="char" char="." rowspan="1" colspan="1">33.0</td><td align="char" char="." rowspan="1" colspan="1">0.262</td><td align="char" char="." rowspan="1" colspan="1">0.740</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">14.3</td><td align="char" char="." rowspan="1" colspan="1">11.7</td><td align="char" char="." rowspan="1" colspan="1">11.3</td><td align="char" char="." rowspan="1" colspan="1">8.8</td><td align="char" char="." rowspan="1" colspan="1">13.0</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="8" align="center" rowspan="1">Gender</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Men</td><td align="char" char="." rowspan="1" colspan="1">1 (25.0)</td><td align="char" char="." rowspan="1" colspan="1">8 (19.5)</td><td align="char" char="." rowspan="1" colspan="1">4 (17.4)</td><td align="char" char="." rowspan="1" colspan="1">1 (10.0)</td><td align="char" char="." rowspan="1" colspan="1">3 (23.1)</td><td align="char" char="." rowspan="1" colspan="1">1.000</td><td align="char" char="." rowspan="1" colspan="1">0.315</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Women</td><td align="char" char="." rowspan="1" colspan="1">3 (75.0)</td><td align="char" char="." rowspan="1" colspan="1">33 (80.5)</td><td align="char" char="." rowspan="1" colspan="1">19 (82.6)</td><td align="char" char="." rowspan="1" colspan="1">9 (90.0)</td><td align="char" char="." rowspan="1" colspan="1">10 (76.9)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="8" align="left" rowspan="1">S&#x02010;IgE milk (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">1.3</td><td align="char" char="." rowspan="1" colspan="1">86.2</td><td align="char" char="." rowspan="1" colspan="1">97.6</td><td align="char" char="." rowspan="1" colspan="1">72.9</td><td align="char" char="." rowspan="1" colspan="1">117.4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">1.6</td><td align="char" char="." rowspan="1" colspan="1">53.3</td><td align="char" char="." rowspan="1" colspan="1">54.7</td><td align="char" char="." rowspan="1" colspan="1">53.3</td><td align="char" char="." rowspan="1" colspan="1">67.4</td><td align="char" char="." rowspan="1" colspan="1">0.057</td><td align="char" char="." rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">0.9</td><td align="char" char="." rowspan="1" colspan="1">105.2</td><td align="char" char="." rowspan="1" colspan="1">113.5</td><td align="char" char="." rowspan="1" colspan="1">74.2</td><td align="char" char="." rowspan="1" colspan="1">143.4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="8" align="left" rowspan="1">S&#x02010;IgE peanut (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">88.9</td><td align="char" char="." rowspan="1" colspan="1">116.2</td><td align="char" char="." rowspan="1" colspan="1">11.6</td><td align="char" char="." rowspan="1" colspan="1">220.9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">23.5</td><td align="char" char="." rowspan="1" colspan="1">19.9</td><td align="char" char="." rowspan="1" colspan="1">8.8</td><td align="char" char="." rowspan="1" colspan="1">54.6</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.057</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">213.0</td><td align="char" char="." rowspan="1" colspan="1">261.5</td><td align="char" char="." rowspan="1" colspan="1">10.7</td><td align="char" char="." rowspan="1" colspan="1">360.9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="8" align="left" rowspan="1">S&#x02010;IgE egg white (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">4.0</td><td align="char" char="." rowspan="1" colspan="1">45.7</td><td align="char" char="." rowspan="1" colspan="1">81.3</td><td align="char" char="." rowspan="1" colspan="1">6.8</td><td align="char" char="." rowspan="1" colspan="1">106.1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">4.0</td><td align="char" char="." rowspan="1" colspan="1">14.5</td><td align="char" char="." rowspan="1" colspan="1">78.2</td><td align="char" char="." rowspan="1" colspan="1">6.8</td><td align="char" char="." rowspan="1" colspan="1">140.0</td><td align="char" char="." rowspan="1" colspan="1">0.500</td><td align="char" char="." rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">65.4</td><td align="char" char="." rowspan="1" colspan="1">81.1</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">78.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="8" align="left" rowspan="1">S&#x02010;IgE (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">877.0</td><td align="char" char="." rowspan="1" colspan="1">1162.6</td><td align="char" char="." rowspan="1" colspan="1">1455.7</td><td align="char" char="." rowspan="1" colspan="1">1385.0</td><td align="char" char="." rowspan="1" colspan="1">1508.8</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">295.0</td><td align="char" char="." rowspan="1" colspan="1">433.0</td><td align="char" char="." rowspan="1" colspan="1">343.5</td><td align="char" char="." rowspan="1" colspan="1">121.0</td><td align="char" char="." rowspan="1" colspan="1">1205.5</td><td align="char" char="." rowspan="1" colspan="1">0.630</td><td align="char" char="." rowspan="1" colspan="1">0.059</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">1209.1</td><td align="char" char="." rowspan="1" colspan="1">1744.3</td><td align="char" char="." rowspan="1" colspan="1">2235.7</td><td align="char" char="." rowspan="1" colspan="1">3132.9</td><td align="char" char="." rowspan="1" colspan="1">1504.9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="8" align="left" rowspan="1">Allergic rhinitis</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">
<italic>n</italic> (%)</td><td align="char" char="." rowspan="1" colspan="1">3 (75.0)</td><td align="char" char="." rowspan="1" colspan="1">28 (68.3)</td><td align="char" char="." rowspan="1" colspan="1">19 (82.6)</td><td align="char" char="." rowspan="1" colspan="1">7 (70.0)</td><td align="char" char="." rowspan="1" colspan="1">12 (92.3)</td><td align="char" char="." rowspan="1" colspan="1">0.383</td><td align="char" char="." rowspan="1" colspan="1">0.231</td></tr><tr><td colspan="8" align="left" rowspan="1">Atopic eczema</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">
<italic>n</italic> (%)</td><td align="char" char="." rowspan="1" colspan="1">3 (75.0)</td><td align="char" char="." rowspan="1" colspan="1">24 (58.5)</td><td align="char" char="." rowspan="1" colspan="1">16 (69.6)</td><td align="char" char="." rowspan="1" colspan="1">5 (55.6)</td><td align="char" char="." rowspan="1" colspan="1">11 (84.6)</td><td align="char" char="." rowspan="1" colspan="1">0.712</td><td align="char" char="." rowspan="1" colspan="1">0.221</td></tr><tr><td colspan="8" align="center" rowspan="1">Asthma</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">
<italic>n</italic> (%)</td><td align="char" char="." rowspan="1" colspan="1">3 (75.0)</td><td align="char" char="." rowspan="1" colspan="1">26 (63.4)</td><td align="char" char="." rowspan="1" colspan="1">16 (69.6)</td><td align="char" char="." rowspan="1" colspan="1">6 (60.0)</td><td align="char" char="." rowspan="1" colspan="1">10 (76.9)</td><td align="char" char="." rowspan="1" colspan="1">1.000</td><td align="char" char="." rowspan="1" colspan="1">0.554</td></tr></tbody></table><permissions><copyright-holder>&#x000a9; 2018 The Authors. Immunity, Inflammation and Disease Published by John Wiley &#x00026; Sons Ltd.</copyright-holder></permissions></table-wrap><p>The patients were allowed to continue the OIT after one year and thus of 23 patients with OIT, 13 patients (56.5%) are still on OIT (six patients (60%) of milk OIT patients, four patients (44%) of peanut OIT, and three patients (75%) on egg white OIT are currently on OIT (Table <xref rid="iid3218-tbl-0001" ref-type="table-wrap">1</xref>). Milk allergic patients had a median of 54.7&#x02009;kU/L allergen specific IgE antibodies before OIT, 30.3&#x02009;kU/L one year after OIT and 10.7&#x02009;kU/L in 2017 (Table <xref rid="iid3218-tbl-0002" ref-type="table-wrap">2</xref>). Peanut allergic patients had a median of 19.9&#x02009;kU/L allergen specific IgE antibodies before OIT, and 32.0&#x02009;kU/L one year after OIT (Table <xref rid="iid3218-tbl-0002" ref-type="table-wrap">2</xref>). However, the average allergen specific IgE in the peanut allergic group decreased from 116.2&#x02009;kU/L, into 32.4&#x02009;kU/L at one year. Likewise, IgE antibodies against <italic>Ara h 2</italic> decreased from an average of 48.8 to 33.0&#x02009;kU/L at one year and 36.4&#x02009;kU/L in 2017. Egg allergic patients had a median of 78.2&#x02009;kU/L allergen specific IgE antibodies before OIT, 46.1&#x02009;kU/L one year after OIT (Table <xref rid="iid3218-tbl-0002" ref-type="table-wrap">2</xref>).</p><table-wrap id="iid3218-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Allergen specific IgE values in milk allergic patients with milk OIT before OIT and at one year of OIT</p></caption><table frame="hsides" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Before OIT</th><th align="center" valign="bottom" rowspan="1" colspan="1">At 1 year</th><th align="center" valign="bottom" rowspan="1" colspan="1">2017</th><th align="center" valign="bottom" rowspan="1" colspan="1">Before vs 1 year (p)</th></tr><tr style="border-bottom:solid 1px #000000"><th colspan="5" align="left" valign="bottom" rowspan="1">Milk allergy and milk OIT</th></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE milk (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">97.6</td><td align="char" char="." rowspan="1" colspan="1">29.3</td><td align="char" char="." rowspan="1" colspan="1">11.0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">54.7</td><td align="char" char="." rowspan="1" colspan="1">30.3</td><td align="char" char="." rowspan="1" colspan="1">10.7</td><td align="char" char="." rowspan="1" colspan="1">0.225</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">113.5</td><td align="char" char="." rowspan="1" colspan="1">18.3</td><td align="char" char="." rowspan="1" colspan="1">8.6</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE casein (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">57.8</td><td align="char" char="." rowspan="1" colspan="1">19.5</td><td align="char" char="." rowspan="1" colspan="1">12.4</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">41</td><td align="char" char="." rowspan="1" colspan="1">14.4</td><td align="char" char="." rowspan="1" colspan="1">10.6</td><td align="char" char="." rowspan="1" colspan="1">0.068</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">60.4</td><td align="char" char="." rowspan="1" colspan="1">17.9</td><td align="char" char="." rowspan="1" colspan="1">11.2</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="center" rowspan="1">S&#x02010;IgE lactalb (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">6.2</td><td align="char" char="." rowspan="1" colspan="1">3.6</td><td align="char" char="." rowspan="1" colspan="1">1.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">3.1</td><td align="char" char="." rowspan="1" colspan="1">3.0</td><td align="char" char="." rowspan="1" colspan="1">1.6</td><td align="char" char="." rowspan="1" colspan="1">0.109</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">7.3</td><td align="char" char="." rowspan="1" colspan="1">4.2</td><td align="char" char="." rowspan="1" colspan="1">1.9</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE &#x003b2;&#x02010;lactogl (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">5.8</td><td align="char" char="." rowspan="1" colspan="1">2.1</td><td align="char" char="." rowspan="1" colspan="1">0.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">2.0</td><td align="char" char="." rowspan="1" colspan="1">0.4</td><td align="char" char="." rowspan="1" colspan="1">0.3</td><td align="char" char="." rowspan="1" colspan="1">0.285</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">9.5</td><td align="char" char="." rowspan="1" colspan="1">3.1</td><td align="char" char="." rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">2201.9</td><td align="char" char="." rowspan="1" colspan="1">1177.3</td><td align="char" char="." rowspan="1" colspan="1">899.0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">464.0</td><td align="char" char="." rowspan="1" colspan="1">1051.0</td><td align="char" char="." rowspan="1" colspan="1">899.0</td><td align="char" char="." rowspan="1" colspan="1">0.18</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">2953.5</td><td align="char" char="." rowspan="1" colspan="1">653.7</td><td align="char" char="." rowspan="1" colspan="1">534.6</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead valign="bottom"><tr><th colspan="5" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Peanut allergy and peanut OIT</th></tr></thead><tbody><tr><td colspan="5" align="center" rowspan="1">S&#x02010;IgE peanut (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">116.2</td><td align="char" char="." rowspan="1" colspan="1">32.4</td><td align="char" char="." rowspan="1" colspan="1">59.2</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">19.9</td><td align="char" char="." rowspan="1" colspan="1">32</td><td align="char" char="." rowspan="1" colspan="1">50.9</td><td align="char" char="." rowspan="1" colspan="1">0.285</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">261.5</td><td align="char" char="." rowspan="1" colspan="1">27.4</td><td align="char" char="." rowspan="1" colspan="1">36.8</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE rArah2 (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">48.8</td><td align="char" char="." rowspan="1" colspan="1">33.0</td><td align="char" char="." rowspan="1" colspan="1">36.4</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">10.6</td><td align="char" char="." rowspan="1" colspan="1">26.8</td><td align="char" char="." rowspan="1" colspan="1">24.0</td><td align="char" char="." rowspan="1" colspan="1">0.893</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">104.1</td><td align="char" char="." rowspan="1" colspan="1">34.5</td><td align="char" char="." rowspan="1" colspan="1">22.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE rArah1 (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">9.1</td><td align="char" char="." rowspan="1" colspan="1">14.7</td><td align="char" char="." rowspan="1" colspan="1">13.8</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">3.0</td><td align="char" char="." rowspan="1" colspan="1">7.4</td><td align="char" char="." rowspan="1" colspan="1">8.4</td><td align="char" char="." rowspan="1" colspan="1">0.273</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">19.7</td><td align="char" char="." rowspan="1" colspan="1">22.7</td><td align="char" char="." rowspan="1" colspan="1">11.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE rArah3 (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">7.8</td><td align="char" char="." rowspan="1" colspan="1">8.4</td><td align="char" char="." rowspan="1" colspan="1">9.6</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">0.4</td><td align="char" char="." rowspan="1" colspan="1">0.5</td><td align="char" char="." rowspan="1" colspan="1">4.1</td><td align="char" char="." rowspan="1" colspan="1">0.593</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">19.9</td><td align="char" char="." rowspan="1" colspan="1">16.1</td><td align="char" char="." rowspan="1" colspan="1">12.8</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="center" rowspan="1">S&#x02010;IgE rArah9 (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">0.5</td><td align="char" char="." rowspan="1" colspan="1">0.4</td><td align="char" char="." rowspan="1" colspan="1">0.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">0.0</td><td align="char" char="." rowspan="1" colspan="1">0.1</td><td align="char" char="." rowspan="1" colspan="1">0.5</td><td align="char" char="." rowspan="1" colspan="1">0.109</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">1.2</td><td align="char" char="." rowspan="1" colspan="1">0.8</td><td align="char" char="." rowspan="1" colspan="1">0.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE rArah8 (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">2.7</td><td align="char" char="." rowspan="1" colspan="1">1.4</td><td align="char" char="." rowspan="1" colspan="1">0.1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">0.0</td><td align="char" char="." rowspan="1" colspan="1">0.1</td><td align="char" char="." rowspan="1" colspan="1">0.1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">3.5</td><td align="char" char="." rowspan="1" colspan="1">1.9</td><td align="char" char="." rowspan="1" colspan="1">0.1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">522.8</td><td align="char" char="." rowspan="1" colspan="1">549.5</td><td align="char" char="." rowspan="1" colspan="1">975.0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">95.5</td><td align="char" char="." rowspan="1" colspan="1">549.5</td><td align="char" char="." rowspan="1" colspan="1">975.0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">892.4</td><td align="char" char="." rowspan="1" colspan="1">613.1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead valign="bottom"><tr><th colspan="5" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Egg white allergy and egg OIT</th></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE egg white (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">81.3</td><td align="char" char="." rowspan="1" colspan="1">47.3</td><td align="char" char="." rowspan="1" colspan="1">32.8</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">78.2</td><td align="char" char="." rowspan="1" colspan="1">46.1</td><td align="char" char="." rowspan="1" colspan="1">32.8</td><td align="char" char="." rowspan="1" colspan="1">0.285</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">81.1</td><td align="char" char="." rowspan="1" colspan="1">40.7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="center" rowspan="1">S&#x02010;IgE ovomucoid (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">22.4</td><td align="char" char="." rowspan="1" colspan="1">28.1</td><td align="char" char="." rowspan="1" colspan="1">12.9</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">20.2</td><td align="char" char="." rowspan="1" colspan="1">20.7</td><td align="char" char="." rowspan="1" colspan="1">12.9</td><td align="char" char="." rowspan="1" colspan="1">0.593</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">15.5</td><td align="char" char="." rowspan="1" colspan="1">22.9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="center" rowspan="1">S&#x02010;IgE conalbumin (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">46.5</td><td align="char" char="." rowspan="1" colspan="1">30.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">46.5</td><td align="char" char="." rowspan="1" colspan="1">17.0</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.317</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">39.1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE ovalbumin (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">38.5</td><td align="char" char="." rowspan="1" colspan="1">20.1</td><td align="char" char="." rowspan="1" colspan="1">15.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">38.0</td><td align="char" char="." rowspan="1" colspan="1">24.5</td><td align="char" char="." rowspan="1" colspan="1">15.7</td><td align="char" char="." rowspan="1" colspan="1">0.285</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">38.0</td><td align="char" char="." rowspan="1" colspan="1">13.7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" rowspan="1">S&#x02010;IgE (kU/L)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean</td><td align="char" char="." rowspan="1" colspan="1">958.7</td><td align="char" char="." rowspan="1" colspan="1">5624.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median</td><td align="char" char="." rowspan="1" colspan="1">551.0</td><td align="char" char="." rowspan="1" colspan="1">5624.5</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.317</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SD</td><td align="char" char="." rowspan="1" colspan="1">1032.7</td><td align="char" char="." rowspan="1" colspan="1">7563.9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="iid3218-note-0001"><p>The respective results for specific IgE values for peanut OIT and egg white OIT.</p></fn></table-wrap-foot><permissions><copyright-holder>&#x000a9; 2018 The Authors. Immunity, Inflammation and Disease Published by John Wiley &#x00026; Sons Ltd.</copyright-holder></permissions></table-wrap><p>The OIT did not affect statistically significantly on the lung function parameters (data not shown).</p><sec id="iid3218-sec-0012"><title>Adverse effects</title><p>Oral and throat itching was the most common side effect of OIT (73.9% of the patients). Four patients (17.4%) reported having used epinephrine autoinjector and three patients (13%) having needed emergency room treatment of all the 23 patients having immunotherapy for either milk, peanut or egg allergy. Epinephrine autoinjector was used at least once by three patients (30.0%) with milk OIT and by one patient (11.1%) with peanut OIT. Four of the milk OIT patients discontinued because of allergic symptoms during escalation phase. One had an emergency visit caused by generalized urticaria. One peanut OIT patient discontinued because of pregnancy during escalation phase. Four peanut OIT patients discontinued because of allergic symptoms during escalation phase. One had flush skin symptoms and stomach pain when changing from peanut margarine (dose 50&#x02009;mg peanut protein) into peanuts (1/4 peanut) at the hospital. Adverse effects led to discontinuation in one egg OIT patient (exacerbation of atopic dermatitis).</p></sec></sec><sec id="iid3218-sec-0013"><title>Discussion</title><p>We report altogether 23 adult patients having started OIT for severe milk, peanut or egg allergy and of these 13 patients are still on immunotherapy. Median length of OIT has been 515 days (SD 754 days). Allergen specific IgE values have decreased in all the food groups during OIT. Mild allergic reactions in all the food OIT groups have been common. 17.4% of all the OIT patients had used epinephrine autoinjector but all the reactions have been managed successfully.</p><p>In a Cochrane review for milk OIT, all the study individuals were children contrary to our adult population. In addition, different OIT protocols were reported making comparison of the studies difficult <xref rid="iid3218-bib-0013" ref-type="ref">13</xref>. In the recent systematic review and meta&#x02010;analysis of allergen immunotherapy for food allergy, altogether 1259 patients were analysed (mostly children) <xref rid="iid3218-bib-0014" ref-type="ref">14</xref>. OIT was effective and increased the threshold for symptoms but was associated with a modest increased risk of serious systemic adverse reactions. Further, the new EAACI guidelines on immunotherapy advises to perform OIT in research centers or in clinical centers with extensive experience in OIT and that the patients should be provided with information about OIT to be able to do an informed decision about the therapy <xref rid="iid3218-bib-0015" ref-type="ref">15</xref>.</p><p>Strengths of the study is the use of oral immunotherapy with food products instead of epicutaneous or sublingual products both of which are known to be less effective than OIT. In addition, the real life setting shows that some individual patients with severe food allergy are willing to seek for treatment that would decrease risk of severe allergic reactions in every&#x02010;day life. We had both milk, peanut and egg white allergic patients and OIT in the study. Although the study population is small, we have relatively long OIT length especially in the milk allergic group (median 672 days). Weakness of the study is the small study population although in phase 2 trials as this the study population is always small. Further, lack of control group makes it more difficult to estimate the study results.</p></sec><sec id="iid3218-sec-0014"><title>Conclusions</title><p>OIT can be given in adult patients with milk, peanut or egg allergy in individual cases. This therapeutic option is not ready to be included in the everyday clinical practice and thus we propose OIT in adults to be performed in clinical trials only. Further, according to these preliminary results, achieving persistent tolerance and cure in adults seems unlikely but alleviating allergy may be achieved.</p></sec><sec id="iid3218-sec-0016"><title>Clinical Implications</title><p>OIT can be given in adult patients with severe milk, peanut or egg allergy only in selected cases. OIT leads into desensitization but it is not clear whether persistent tolerance can be achieved. Mild adverse events during OIT are common.</p></sec></body><back><ack id="iid3218-sec-0015"><title>Acknowledgments</title><p>We thank sincerely our study patients that were willing to seek for alleviation in their allergy without fear. We thank skilled nurse Tanja Utriainen.</p></ack><ref-list id="iid3218-bibl-0001" content-type="cited-references"><title>References</title><ref id="iid3218-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="iid3218-cit-0001">
<string-name>
<surname>Schneider Chafen</surname>, <given-names>J. J.</given-names>
</string-name>, 
<string-name>
<given-names>S. J.</given-names>
<surname>Newberry</surname>
</string-name>, and 
<string-name>
<given-names>M. A.</given-names>
<surname>Riedl</surname>
</string-name>. 
<year>2010</year>
<article-title>Diagnosing and managing common food allergies: a systematic review</article-title>. 
<source>JAMA</source>
<volume>303</volume>:<fpage>1848</fpage>&#x02013;<lpage>1856</lpage>.
<pub-id pub-id-type="pmid">20460624</pub-id></mixed-citation></ref><ref id="iid3218-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="iid3218-cit-0002">
<string-name>
<surname>Longo</surname>, <given-names>G.</given-names>
</string-name>, 
<string-name>
<given-names>E.</given-names>
<surname>Barbi</surname>
</string-name>, and 
<string-name>
<given-names>I.</given-names>
<surname>Berti</surname>
</string-name>. 
<year>2008</year>
<article-title>Spesific oral tolerance induction in children with very severe cow's milk&#x02010;induced reactons</article-title>. 
<source>J. Allergy Clin. Immunol</source>. 
<volume>121</volume>(<issue>2</issue>):<fpage>343</fpage>&#x02013;<lpage>347</lpage>.
<pub-id pub-id-type="pmid">18158176</pub-id></mixed-citation></ref><ref id="iid3218-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="iid3218-cit-0003">
<string-name>
<surname>Martorell</surname>, <given-names>A.</given-names>
</string-name>, 
<string-name>
<given-names>B.</given-names>
<surname>De Ia Hoz</surname>
</string-name>, and 
<string-name>
<given-names>M. D.</given-names>
<surname>Ib&#x000e1;&#x000f1;ez</surname>
</string-name>. 
<year>2011</year>
<article-title>Oral desensitization as a useful treatment in 2&#x02010;year&#x02010;old children with cow&#x000e1;s milk allergy</article-title>. 
<source>Clin. Exp. Allergy</source>
<volume>41</volume>(<issue>9</issue>):<fpage>1297</fpage>&#x02013;<lpage>1304</lpage>.
<pub-id pub-id-type="pmid">21481024</pub-id></mixed-citation></ref><ref id="iid3218-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="iid3218-cit-0004">
<string-name>
<surname>Pajno</surname>, <given-names>G. B.</given-names>
</string-name>, 
<string-name>
<given-names>L.</given-names>
<surname>Caminiti</surname>
</string-name>, and 
<string-name>
<given-names>P.</given-names>
<surname>Ruggeri</surname>
</string-name>. 
<year>2010</year>
<article-title>Oral immunotherapy for cow's milk allergy with a weekly up&#x02010;dosing regimen: a randomized single&#x02010;blind controlled study</article-title>. 
<source>Ann. Allergy. Asthma. Immunol</source>. 
<volume>105</volume>(<issue>5</issue>):<fpage>376</fpage>&#x02013;<lpage>381</lpage>.
<pub-id pub-id-type="pmid">21055664</pub-id></mixed-citation></ref><ref id="iid3218-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="iid3218-cit-0005">
<string-name>
<surname>Burks</surname>, <given-names>A. W.</given-names>
</string-name>, 
<string-name>
<given-names>S. M.</given-names>
<surname>Jones</surname>
</string-name>, and 
<string-name>
<given-names>R. A.</given-names>
<surname>Wood</surname>
</string-name>. 
<year>2012</year>
<article-title>Oral immunotherapy for treatment of egg allergy in children</article-title>. 
<source>N. Engl. J. Med</source>. 
<volume>367</volume>(<issue>3</issue>):<fpage>233</fpage>&#x02013;<lpage>243</lpage>.
<pub-id pub-id-type="pmid">22808958</pub-id></mixed-citation></ref><ref id="iid3218-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="iid3218-cit-0006">
<string-name>
<surname>Kukkonen</surname>, <given-names>A. K.</given-names>
</string-name>, 
<string-name>
<given-names>R.</given-names>
<surname>Uotila</surname>
</string-name>, 
<string-name>
<given-names>L. P.</given-names>
<surname>Malmberg</surname>
</string-name>, 
<string-name>
<given-names>A. S.</given-names>
<surname>Pelkonen</surname>
</string-name>, and 
<string-name>
<given-names>M. J.</given-names>
<surname>M&#x000e4;kel&#x000e4;</surname>
</string-name>. 
<year>2017</year>
<article-title>Double&#x02010;blind placebo&#x02010;controlled challenge showed that peanut oral immunotherapy was effective for severe allergy without negative effects on airway inflammation</article-title>. 
<source>Acta Paediatr</source>. 
<volume>106</volume>:<fpage>274</fpage>&#x02013;<lpage>281</lpage>.
<pub-id pub-id-type="pmid">27859599</pub-id></mixed-citation></ref><ref id="iid3218-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="iid3218-cit-0007">
<string-name>
<surname>Crapo</surname>, <given-names>R. O.</given-names>
</string-name>, 
<string-name>
<given-names>R.</given-names>
<surname>Casaburi</surname>
</string-name>, 
<string-name>
<given-names>A. L.</given-names>
<surname>Coates</surname>
</string-name>, 
<string-name>
<given-names>P. L.</given-names>
<surname>Enright</surname>
</string-name>, 
<string-name>
<given-names>J. L.</given-names>
<surname>Hankinson</surname>
</string-name>, 
<string-name>
<given-names>C. G.</given-names>
<surname>Irvin</surname>
</string-name>, 
<string-name>
<given-names>N. R.</given-names>
<surname>MacIntyre</surname>
</string-name>, 
<string-name>
<given-names>R. T.</given-names>
<surname>McKay</surname>
</string-name>, 
<string-name>
<given-names>J. S.</given-names>
<surname>Wanger</surname>
</string-name>, 
<string-name>
<given-names>S. D.</given-names>
<surname>Anderson</surname>
</string-name>, et al. <article-title>Guidelines for methacholine and exercise challenge testing1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999</article-title>. 
<source>Am. J. Respir. Crit. Care Med</source>. 
<volume>2000</volume>(<issue>161</issue>):<fpage>309</fpage>&#x02013;<lpage>329</lpage>.
</mixed-citation></ref><ref id="iid3218-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="iid3218-cit-0008">
<string-name>
<surname>Vlieg&#x02010;Boestra</surname>, <given-names>B. J.</given-names>
</string-name>, 
<string-name>
<given-names>L.</given-names>
<surname>Herpertz</surname>
</string-name>, 
<string-name>
<given-names>S.</given-names>
<surname>van der Heide</surname>
</string-name>, 
<string-name>
<given-names>J.</given-names>
<surname>Kukler</surname>
</string-name>, 
<string-name>
<given-names>C.</given-names>
<surname>Jansink</surname>
</string-name>, 
<string-name>
<given-names>W.</given-names>
<surname>Vaessen</surname>
</string-name>, 
<string-name>
<given-names>B. J.</given-names>
<surname>Beusekamp</surname>
</string-name>, and 
<string-name>
<given-names>A. E.</given-names>
<surname>Dubois</surname>
</string-name>. 
<year>2011</year>
<article-title>Validation of novel recipes for double&#x02010;blind, placebo&#x02010;controlled food challenges in children and adults</article-title>. 
<source>Allergy</source>
<volume>66</volume>:<fpage>948</fpage>&#x02013;<lpage>954</lpage>.
<pub-id pub-id-type="pmid">21255039</pub-id></mixed-citation></ref><ref id="iid3218-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="iid3218-cit-0009">
<string-name>
<surname>Muraro</surname>, <given-names>A.</given-names>
</string-name>, 
<string-name>
<given-names>T.</given-names>
<surname>Werfel</surname>
</string-name>, 
<string-name>
<given-names>K.</given-names>
<surname>Hoffmann&#x02010;Sommergruber</surname>
</string-name>, 
<string-name>
<given-names>G.</given-names>
<surname>Roberts</surname>
</string-name>, 
<string-name>
<given-names>K.</given-names>
<surname>Beyer</surname>
</string-name>, 
<string-name>
<given-names>C.</given-names>
<surname>Bindslev&#x02010;Jensen</surname>
</string-name>, 
<string-name>
<given-names>V.</given-names>
<surname>Cardona</surname>
</string-name>, 
<string-name>
<given-names>A.</given-names>
<surname>Dubois</surname>
</string-name>, 
<string-name>
<given-names>G.</given-names>
<surname>duToit</surname>
</string-name>, 
<string-name>
<given-names>P.</given-names>
<surname>Eigenmann</surname>
</string-name>, 
<string-name>
<given-names>M.</given-names>
<surname>Fernandez Rivas</surname>
</string-name>, et al. 
<year>2014</year>
<article-title>EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy</article-title>. 
<source>Allergy</source>
<volume>69</volume>:<fpage>1008</fpage>&#x02013;<lpage>1025</lpage>.
<pub-id pub-id-type="pmid">24909706</pub-id></mixed-citation></ref><ref id="iid3218-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="iid3218-cit-0010">
<string-name>
<surname>Meglio</surname>, <given-names>P.</given-names>
</string-name>, 
<string-name>
<given-names>E.</given-names>
<surname>Bartone</surname>
</string-name>, 
<string-name>
<given-names>M.</given-names>
<surname>Plantamura</surname>
</string-name>, 
<string-name>
<given-names>E.</given-names>
<surname>Arabito</surname>
</string-name>, and 
<string-name>
<given-names>P. G.</given-names>
<surname>Giampietro</surname>
</string-name>. 
<year>2004</year>
<article-title>A protocol for oral desensitization in children with IgE&#x02010;mediated cow's milk allergy</article-title>. 
<source>Allergy</source>
<volume>59</volume>:<fpage>980</fpage>&#x02013;<lpage>987</lpage>.
<pub-id pub-id-type="pmid">15291907</pub-id></mixed-citation></ref><ref id="iid3218-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="iid3218-cit-0011">
<string-name>
<surname>Kuitunen</surname>, <given-names>M.</given-names>
</string-name>, 
<string-name>
<given-names>H.</given-names>
<surname>Englund</surname>
</string-name>, 
<string-name>
<given-names>S.</given-names>
<surname>Remes</surname>
</string-name>, 
<string-name>
<given-names>R.</given-names>
<surname>Mov&#x000e9;rare</surname>
</string-name>, 
<string-name>
<given-names>A.</given-names>
<surname>Pelkonen</surname>
</string-name>, 
<string-name>
<given-names>M. P.</given-names>
<surname>Borres</surname>
</string-name>, and 
<string-name>
<given-names>M. J.</given-names>
<surname>M&#x000e4;kel&#x000e4;</surname>
</string-name>. 
<year>2015</year>
<article-title>High IgE&#x02010;levels to &#x003b1;&#x02010;lactalbumin, &#x003b2;&#x02010;lactoglobulin and casein predict less successful cow's milk oral immunotherapy</article-title>. 
<source>Allergy</source>
<volume>70</volume>:<fpage>955</fpage>&#x02013;<lpage>962</lpage>.
<pub-id pub-id-type="pmid">25951431</pub-id></mixed-citation></ref><ref id="iid3218-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="iid3218-cit-0012">
<string-name>
<surname>Jones</surname>, <given-names>S. M.</given-names>
</string-name>, 
<string-name>
<given-names>A. W.</given-names>
<surname>Burks</surname>
</string-name>, 
<string-name>
<given-names>C.</given-names>
<surname>Keet</surname>
</string-name>, 
<string-name>
<given-names>B. P.</given-names>
<surname>Vickery</surname>
</string-name>, 
<string-name>
<given-names>A. M.</given-names>
<surname>Scurlock</surname>
</string-name>, 
<string-name>
<given-names>R. A.</given-names>
<surname>Wood</surname>
</string-name>, 
<string-name>
<given-names>A. H.</given-names>
<surname>Liu</surname>
</string-name>, 
<string-name>
<given-names>S. H.</given-names>
<surname>Sicherer</surname>
</string-name>, 
<string-name>
<given-names>A. K.</given-names>
<surname>Henning</surname>
</string-name>, and 
<string-name>
<given-names>R. W.</given-names>
<surname>Lindblad</surname>
</string-name>. 
<year>2016</year>
<article-title>Long&#x02010;term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy</article-title>. 
<source>J. Allergy Clin. Immunol</source>. 
<volume>137</volume>:<fpage>1117</fpage>&#x02013;<lpage>1127</lpage>.
<pub-id pub-id-type="pmid">26924470</pub-id></mixed-citation></ref><ref id="iid3218-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="iid3218-cit-0013">
<string-name>
<surname>Yeung</surname>, <given-names>J. P.</given-names>
</string-name>, 
<string-name>
<given-names>L. A.</given-names>
<surname>Kloda</surname>
</string-name>, 
<string-name>
<given-names>J.</given-names>
<surname>McDevitt</surname>
</string-name>, 
<string-name>
<given-names>M.</given-names>
<surname>Ben&#x02010;Shoshan</surname>
</string-name>, and 
<string-name>
<given-names>R.</given-names>
<surname>Alizadehfar</surname>
</string-name>. 
<year>2012</year>
<article-title>Oral immunotherapy for milk allergy</article-title>. 
<source>Cochrane Database Syst. Rev</source>. 
<volume>11</volume>:<fpage>CD009542</fpage>.
<pub-id pub-id-type="pmid">23152278</pub-id></mixed-citation></ref><ref id="iid3218-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="iid3218-cit-0014">
<string-name>
<surname>Nurmatov</surname>, <given-names>U</given-names>
</string-name>, 
<string-name>
<given-names>S.</given-names>
<surname>Dhami</surname>
</string-name>, 
<string-name>
<given-names>S.</given-names>
<surname>Arasi</surname>
</string-name>, 
<string-name>
<given-names>G. B.</given-names>
<surname>Pajno</surname>
</string-name>, 
<string-name>
<given-names>M.</given-names>
<surname>Fernandez&#x02010;Rivas</surname>
</string-name>, 
<string-name>
<given-names>A.</given-names>
<surname>Muraro</surname>
</string-name>, 
<string-name>
<given-names>G.</given-names>
<surname>Roberts</surname>
</string-name>, 
<string-name>
<given-names>C.</given-names>
<surname>Akdis</surname>
</string-name>, 
<string-name>
<given-names>M.</given-names>
<surname>Alvaro&#x02010;Lozano</surname>
</string-name>, 
<string-name>
<given-names>K.</given-names>
<surname>Beyer</surname>
</string-name>, et al. 
<year>2017</year>
<article-title>Allergen immunotherapy for IgE&#x02010;mediated food allergy: a systematic review and meta&#x02010;analysis</article-title>. 
<source>Allergy</source>
<fpage>1133</fpage>&#x02013;<lpage>1147</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/all.13124">https://doi.org/10.1111/all.13124</ext-link>
<pub-id pub-id-type="pmid">28058751</pub-id></mixed-citation></ref><ref id="iid3218-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="iid3218-cit-0015">
<string-name>
<surname>Pajno</surname>, <given-names>G. B.</given-names>
</string-name>, 
<string-name>
<given-names>M.</given-names>
<surname>Fernandez&#x02010;Rivas</surname>
</string-name>, 
<string-name>
<given-names>S.</given-names>
<surname>Asasi</surname>
</string-name>, 
<string-name>
<given-names>G.</given-names>
<surname>Roberts</surname>
</string-name>, 
<string-name>
<given-names>C. A.</given-names>
<surname>Akdis</surname>
</string-name>, 
<string-name>
<given-names>M.</given-names>
<surname>Alvaro&#x02010;Lozano</surname>
</string-name>, 
<string-name>
<given-names>K.</given-names>
<surname>Beyer</surname>
</string-name>, 
<string-name>
<given-names>C.</given-names>
<surname>Bindslev&#x02010;Jensen</surname>
</string-name>, 
<string-name>
<given-names>W.</given-names>
<surname>Burks</surname>
</string-name>, 
<string-name>
<given-names>M.</given-names>
<surname>Ebisawa</surname>
</string-name>, et al. 
<year>2017</year>
<article-title>EAACI guidelines on allergen immunotherapy: IgE mediated food allergy</article-title>. 
<source>Allergy</source>, in press.
</mixed-citation></ref></ref-list></back></article>